JAAD Case Reports · 2015 · 21 citations · 6 references
Life SciencesImmunologyPharmacotherapyImmunopathologyImmunotherapyInflammationImmune-mediated Inflammatory DiseasesInflammatory Disease PharmacotherapyInflammatory MediatorsInflammatory SignalingInflammatory Skin DiseasesInflammatory Skin DisordersBiologic Anti-inflammatory AgentsCytokine TargetingCytokine-mediated Skin InflammationInflammatory CascadeKeratinocyte-mediated ImmunityPsoriasis ImmunopathologyPsoriasis TherapyTumor Necrosis Factor Therapy
Psoriasis, a chronic cutaneous inflammatory disease, is an immune-mediated disorder caused by complex interactions between dendritic cells, T cells, and keratinocytes. Tumor necrosis factor alfa (TNF-α) is a cytokine that plays a major role in the inflammatory cascade.1 Biologic agents that target TNF-α such as etanercept, infliximab, and adalimumab are effective in the treatment of psoriasis.2
6
The association of psoriasis with autoimmune diseases
Jashin J. Wu, Thao Nguyen, Kwun‐Yee T. Poon et al. · Journal of the American Academy of Dermatology · 2012 · 229 citations
Medicine, Dermatology, Immunology +12